Shares of Oramed Pharmaceuticals Inc. ORMP, -76.56% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or secon...
Shares of Oramed Pharmaceuticals Inc. ORMP, -76.56% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or secon...